![Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12964-022-00902-7/MediaObjects/12964_2022_902_Figa_HTML.png)
Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text
![Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17deb256-0db6-484c-8313-bdd8fe4938fe/bjh14339-fig-0001-m.jpg)
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library
![Virus epstein barr - Mononucleoza infectioasa: cum se manifesta, cum se transmite cauze si cum poate fi tratata Virus epstein barr - Mononucleoza infectioasa: cum se manifesta, cum se transmite cauze si cum poate fi tratata](http://malaimare.ro/images/7c25d21dcb907282771814b7baf7b02e.jpg)
Virus epstein barr - Mononucleoza infectioasa: cum se manifesta, cum se transmite cauze si cum poate fi tratata
![Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/3d5690df-0de6-493c-8788-cf4d81073686/gr1_lrg.jpg)
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine
![Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis](https://www.frontiersin.org/files/MyHome%20Article%20Library/665718/665718_Thumb_400.jpg)
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
![DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/41afef97-6285-4e18-8e94-61501be728ba/fx1.jpg)
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics
![A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26912-6/MediaObjects/41467_2021_26912_Fig1_HTML.png)
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
![EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count - International Journal of Infectious Diseases EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7c02685e-e8f4-4d61-bd86-452f6cb68de8/gr1_lrg.jpg)
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count - International Journal of Infectious Diseases
![Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study](https://www.frontiersin.org/files/Articles/991662/fimmu-13-991662-HTML/image_m/fimmu-13-991662-g001.jpg)
Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
![Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/CMR.00044-10/asset/cc13d41f-0a67-42c6-b353-bcc2d249468e/assets/graphic/zcm9990923420002.jpeg)